Panitumumab-Based EGFR Blockade in SMARCB1-Deficient Renal Medullary Carcinoma: Preclinical Basis and Prospective Clinical Activity.

Zacharias NM, Rupe ES, Chen X, Kotecha RR, Rieke DT, McGregor BA, Pesquera P, Yu Z, Grover A, Daw NC, Wang E, Chan SWS, Douglas-Lindsay D, Fan AC, Knoche EM, Kyriakopoulos CE, Lalani AA, Mantia CM, Merla A, Voss MH, Pfanzelter N, Ramakrishna S, Reaume NM, Tang T, Ingram DR, Shamsutdinova D, Wani KM, Wang WL, Lazar AJ, Sheth RA, Rao P, Grimm SL, Coarfa C, He R, Qian J, Duan F, Bisht D, Chauhan PK, Perelli L, Genovese G, Yang L, Lin C, Karam JA, La Posta L, Dondossola E, Basar R, Uprety N, Rezvani K, Gao J, Wang L, Solis Soto LM, Lim B, Tannir NM, Karki M, Msaouel P

Open source

DOI: 10.1158/1078-0432.ccr-26-0392
Published: 2026 Nov 2
Container: Clinical cancer research : an official journal of the American Association for Cancer Research
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1158/1078-0432.ccr-26-0392,
  title = {Panitumumab-Based EGFR Blockade in SMARCB1-Deficient Renal Medullary Carcinoma: Preclinical Basis and Prospective Clinical Activity.},
  author = {Zacharias NM and Rupe ES and Chen X and Kotecha RR and Rieke DT and McGregor BA and Pesquera P and Yu Z and Grover A and Daw NC and Wang E and Chan SWS and Douglas-Lindsay D and Fan AC and Knoche EM and Kyriakopoulos CE and Lalani AA and Mantia CM and Merla A and Voss MH and Pfanzelter N and Ramakrishna S and Reaume NM and Tang T and Ingram DR and Shamsutdinova D and Wani KM and Wang WL and Lazar AJ and Sheth RA and Rao P and Grimm SL and Coarfa C and He R and Qian J and Duan F and Bisht D and Chauhan PK and Perelli L and Genovese G and Yang L and Lin C and Karam JA and La Posta L and Dondossola E and Basar R and Uprety N and Rezvani K and Gao J and Wang L and Solis Soto LM and Lim B and Tannir NM and Karki M and Msaouel P},
  year = {2026},
  journal = {Clinical cancer research : an official journal of the American Association for Cancer Research},
  doi = {10.1158/1078-0432.ccr-26-0392},
  url = {https://doi.org/10.1158/1078-0432.ccr-26-0392}
}

RIS

TY  - JOUR
TI  - Panitumumab-Based EGFR Blockade in SMARCB1-Deficient Renal Medullary Carcinoma: Preclinical Basis and Prospective Clinical Activity.
AU  - Zacharias NM
AU  - Rupe ES
AU  - Chen X
AU  - Kotecha RR
AU  - Rieke DT
AU  - McGregor BA
AU  - Pesquera P
AU  - Yu Z
AU  - Grover A
AU  - Daw NC
AU  - Wang E
AU  - Chan SWS
AU  - Douglas-Lindsay D
AU  - Fan AC
AU  - Knoche EM
AU  - Kyriakopoulos CE
AU  - Lalani AA
AU  - Mantia CM
AU  - Merla A
AU  - Voss MH
AU  - Pfanzelter N
AU  - Ramakrishna S
AU  - Reaume NM
AU  - Tang T
AU  - Ingram DR
AU  - Shamsutdinova D
AU  - Wani KM
AU  - Wang WL
AU  - Lazar AJ
AU  - Sheth RA
AU  - Rao P
AU  - Grimm SL
AU  - Coarfa C
AU  - He R
AU  - Qian J
AU  - Duan F
AU  - Bisht D
AU  - Chauhan PK
AU  - Perelli L
AU  - Genovese G
AU  - Yang L
AU  - Lin C
AU  - Karam JA
AU  - La Posta L
AU  - Dondossola E
AU  - Basar R
AU  - Uprety N
AU  - Rezvani K
AU  - Gao J
AU  - Wang L
AU  - Solis Soto LM
AU  - Lim B
AU  - Tannir NM
AU  - Karki M
AU  - Msaouel P
PY  - 2026
JO  - Clinical cancer research : an official journal of the American Association for Cancer Research
DO  - 10.1158/1078-0432.ccr-26-0392
UR  - https://doi.org/10.1158/1078-0432.ccr-26-0392
ER  -

APA

NM, Z., ES, R., X, C., RR, K., DT, R., BA, M., P, P., Z, Y., A, G., NC, D., E, W., SWS, C., D, D., AC, F., EM, K., CE, K., AA, L., CM, M., A, M., MH, V., N, P., S, R., NM, R., T, T., DR, I., D, S., KM, W., WL, W., AJ, L., RA, S., P, R., SL, G., C, C., R, H., J, Q., F, D., D, B., PK, C., L, P., G, G., L, Y., C, L., JA, K., L, L. P., E, D., R, B., N, U., K, R., J, G., L, W., LM, S. S., B, L., NM, T., M, K., & P, M. (2026). Panitumumab-Based EGFR Blockade in SMARCB1-Deficient Renal Medullary Carcinoma: Preclinical Basis and Prospective Clinical Activity.. Clinical cancer research : an official journal of the American Association for Cancer Research. https://doi.org/10.1158/1078-0432.ccr-26-0392

Source records

pubmed · retrieved 2026-11-11T03:31:25.783Z